CHM chimeric therapeutics limited

Ann: Phase 1B ADVENT-AML trial to be presented at ASH meeting, page-2

  1. 280 Posts.
    lightbulb Created with Sketch. 66
    this should keep CHM front of mind in the AML space...

    Phase 1b pre registration trial as front line combo with SOC...

    Who here has focused on the AML Market opportunity this presents...

    https://hotcopper.com.au/data/attachments/5806/5806288-d12577e8b94465924284acfb20035d08.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $19.57K 4.893M

Buyers (Bids)

No. Vol. Price($)
4 419507 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 18587873 22
View Market Depth
Last trade - 15.59pm 27/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.